Cargando…
Reducing Central Venous Catheter Use in Peripheral Blood Stem Cell Donation: Quality Improvement Report
Peripheral blood stem cell (PBSC) collection from donors through apheresis has become the main source of stem cells for hematopoietic stem cell transplantation. This procedure requires a high blood flow venous access. A peripheral venous catheter (PVC), compared to a central venous catheter (CVC), i...
Autores principales: | Ghazi, Samer, Alaskar, Ahmed, Alzahrani, Mohsen, Damlaj, Moussab, Abuelgasim, Khadega A, Gmati, Giamal, Alshami, Mona, Alshammary, Salman, Al-Surimi, Khaled, Salama, Hind, Alhejazi, Ayman, Jazieh, Abdul-Rahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411715/ https://www.ncbi.nlm.nih.gov/pubmed/28469899 http://dx.doi.org/10.1136/bmjquality.u211975.w4817 |
Ejemplares similares
-
Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
por: Abuelgasim, Khadega A., et al.
Publicado: (2020) -
Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era
por: Abuelgasim, Khadega A, et al.
Publicado: (2021) -
Improving physician's hand over among oncology staff using standardized communication tool
por: Alolayan, Ashwaq, et al.
Publicado: (2017) -
Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
por: Damlaj, Moussab, et al.
Publicado: (2017) -
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
por: Abuelgasim, Khadega A., et al.
Publicado: (2019)